Cooperative Agreement R3926992

This $286,820 federal Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) supports research to validate a machine learning model for predicting mortality risk in pediatric patients eligible for organ donation after circulatory death. The project aims to (1) assess the performance of the "DONATE" model at different time points prior to terminal extubation, and...

This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support a 5-year research project led by Dr. Carrie Thiessen at the University of Wisconsin-Madison. The $193,652 award aims to assess the impact of cognitive biases on patient and provider willingness to accept imperfect kidneys for transplantation. The project has three specific aims: 1)...

This Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) provides $1,800,000 to Missouri University of Science & Technology to develop an artificial intelligence decision support system for kidney transplant healthcare. The goal is to reduce kidney discard rates by at least 10% by embedding preferences and fairness considerations into AI models used to match donor kidneys with transplant centers. Two subawards totaling $XXX,XXX are provided to Saint...

This federal Project Grant award of $138,009 from the Agency for Healthcare Research and Quality (AHRQ), under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, aims to develop predictive models and data visualization tools to increase pediatric donor heart utilization and reduce waitlist mortality. The University of Virginia, as the prime awardee, will leverage machine learning technology to analyze over 30,000 pediatric heart transplant offers from 2010-2020. This...

This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to advance understanding of the impact of APOL1 kidney-risk variants on transplant outcomes for African American deceased donor kidneys. The $641,873 award to Wake Forest University Health Sciences will fund a trans-omics analysis to identify kidney-specific genetic and transcriptomic factors...

This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $394,696 to The Children's Hospital Corporation (Boston Children's Hospital) to study the implementation of social risk screening and referral programs in pediatric inpatient settings across different hospital types. The key objectives are to: 1) Survey and interview clinical leaders from a national network of hospitals to assess...

This $200,000 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a case-cohort study to identify novel determinants of living kidney donor risk. The study aims to improve the counseling and selection of living kidney donors by developing tools for tailored risk prediction based on donor characteristics. Key activities include conducting...

This $197,250 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a study to examine the impact of the Social Worker Outreach and Resource Delivery (SWORD) intervention on individuals bereaved by drug overdose. The study will leverage the random selection process used by the New York City Office of the Chief Medical Examiner to offer the SWORD intervention, which integrates evidence-based strategies to...

This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $159,000.00 to the University of Pittsburgh to examine the feasibility of a randomized controlled trial comparing the synergistic effects of strategy training plus acceptance and commitment therapy (ST+ACT) to strategy training (ST) alone for improving social participation, psychological flexibility, and well-being...

This Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), provides $994,004 to Boston Medical Center Corporation (BMC) to engage adolescents, young adults, families, youth providers, pharmacists, and people who use drugs to generate insights for developing overdose prevention interventions tailored to youth. The key activities include: 1) Exploring perceptions of overdose risk, drug supply, and safety...